Role of IQGAP1 in Papillomavirus-Associated Head and Neck Tumorigenesis
Abstract
:Simple Summary
Abstract
1. Introduction
2. Methods and Materials
2.1. Cell Culture
2.2. CRISPR-Cas9 Cell Line Generation
2.3. Immunoblotting
2.4. Mice
2.5. Primary Mouse Keratinocyte Isolation and Cell Line Establishment
2.6. MmuPV1 Infection of Keratinocytes
2.7. MmuPV1 Infection of Tongue Epithelium
2.8. Oral Swabbing and Detection of MmuPV1 E2 by qPCR
2.9. BrdU Incorporation
2.10. Immunohistochemistry
2.11. RNA In Situ Hybridization
2.12. 4-Nitroquinoline-1-Oxide (4NQO) Induced Head and Neck Carcinogenesis Study
2.13. Overt Tumor and Histological Analyses
2.14. Statistical Analysis
3. Results
3.1. IQGAP1 Is Necessary for HPV-Induced PI3K Signaling
3.2. MmuPV1 Infection Upregulates PI3K Signaling in Keratinocytes
3.3. IQGAP1 Contributes to PV-Associated Head and Neck Tumorigenesis in an Infection-Based Model
3.4. Biomarker Analysis of MmuPV1-Induced Oral Tumors Arising in Iqgap1+/+ and Iqgap1−/− Mice
3.5. IQGAP1 Does Not Impact Head and Neck Carcinogenesis in an HPV16-Transgenic Mouse Model
3.6. Iqgap1+/+K14E6E7 and Iqgap1−/− K14E6E7 Mice Showed Similar Biomarker Patterns
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Cancers Associated with Human Papillomavirus, United States—2013–2017; CDC: Atlanta, GA, USA, 2020.
- Hellner, K.; Münger, K. Human papillomaviruses as therapeutic targets in human cancer. J. Clin. Oncol. 2011, 29, 1785–1794. [Google Scholar] [CrossRef] [PubMed]
- Cancer Facts and Figures 2019; American Cancer Society: Atlanta, GA, USA, 2019.
- Marur, S.; D’Souza, G.; Westra, W.H.; Forastiere, A.A. HPV-associated head and neck cancer: A virus-related cancer epidemic. Lancet Oncol. 2010, 11, 781–789. [Google Scholar] [CrossRef] [Green Version]
- Gillison, M.L. Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers. J. Natl. Cancer Inst. 2000, 92, 709–720. [Google Scholar] [CrossRef] [PubMed]
- National Center for Health Statistics. Health, United States 2018 Chartbook; National Center for Health Statistics: Hyattsville, MD, USA, 2019. [Google Scholar]
- Mahal, B.A.; Catalano, P.J.; Haddad, R.I.; Hanna, G.J.; Kass, J.I.; Schoenfeld, J.D.; Tishler, R.B.; Margalit, D.N. Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States. Cancer Epidemiol. Biomarkers Prev. 2019, 28, 1660–1667. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021. [Google Scholar] [CrossRef] [PubMed]
- Bruni, L.; Diaz, M.; Barrionuevo-Rosas, L.; Herrero, R.; Bray, F.; Bosch, F.X.; de Sanjosé, S.; Castellsagué, X. Global estimates of human papillomavirus vaccination coverage by region and income level: A pooled analysis. Lancet Glob. Health 2016, 4, e453–e463. [Google Scholar] [CrossRef] [Green Version]
- Boersma, P.; Black, L.I. Human Papillomavirus Vaccination Among Adults Aged 18−26, 2013−2018 Key findings Data from the National Health Interview Survey; National Center for Health Statistics: Hyattsville, MD, USA, 2020. [Google Scholar]
- Cancer Genome Atlas Network Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015, 517, 576–582. [CrossRef] [Green Version]
- Stelzer, M.K.; Pitot, H.C.; Liem, A.; Lee, D.; Kennedy, G.D.; Lambert, P.F. Rapamycin Inhibits Anal Carcinogenesis in Two Preclinical Animal Models. Cancer Prev. Res. 2010, 3, 1542–1551. [Google Scholar] [CrossRef] [Green Version]
- Shin, M.-K.; Payne, S.; Bilger, A.; Matkowskyj, K.A.; Carchman, E.; Meyer, D.S.; Bentires-Alj, M.; Deming, D.A.; Lambert, P.F. Activating Mutations in Pik3ca Contribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes. Clin. Cancer Res. 2019, 25, 1889–1900. [Google Scholar] [CrossRef]
- Nichols, A.C.; Palma, D.A.; Chow, W.; Tan, S.; Rajakumar, C.; Rizzo, G.; Fung, K.; Kwan, K.; Wehrli, B.; Winquist, E.; et al. High frequency of activating PIK3CA mutations in human papillomavirus—Positive oropharyngeal cancer. JAMA Otolaryngol. Head Neck Surg. 2013, 139, 617–622. [Google Scholar] [CrossRef] [Green Version]
- Molinolo, A.A.; Marsh, C.; El Dinali, M.; Gangane, N.; Jennison, K.; Hewitt, S.; Patel, V.; Seiwert, T.Y.; Gutkind, J.S. mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas. Clin. Cancer Res. 2012, 18, 2558–2568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Madera, D.; Vitale-Cross, L.; Martin, D.; Schneider, A.; Molinolo, A.A.; Gangane, N.; Carey, T.E.; McHugh, J.B.; Komarck, C.M.; Walline, H.M.; et al. Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3. Cancer Prev. Res. 2015, 8, 197–207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Callejas-Valera, J.L.; Iglesias-Bartolome, R.; Amornphimoltham, P.; Palacios-Garcia, J.; Martin, D.; Califano, J.A.; Molinolo, A.A.; Gutkind, J.S. mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6/E7 mouse model. Carcinogenesis 2016, 37, 1014–1025. [Google Scholar] [CrossRef] [Green Version]
- Kozaki, K.; Imoto, I.; Pimkhaokham, A.; Hasegawa, S.; Tsuda, H.; Omura, K.; Inazawa, J. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma. Cancer Sci. 2006, 97, 1351–1358. [Google Scholar] [CrossRef]
- Woenckhaus, J.; Steger, K.; Werner, E.; Fenic, I.; Gamerdinger, U.; Dreyer, T.; Stahl, U. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J. Pathol. 2002, 198, 335–342. [Google Scholar] [CrossRef]
- Lui, V.W.Y.; Hedberg, M.L.; Li, H.; Vangara, B.S.; Pendleton, K.; Zeng, Y.; Lu, Y.; Zhang, Q.; Du, Y.; Gilbert, B.R.; et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013, 3, 761–769. [Google Scholar] [CrossRef] [Green Version]
- Choi, S.; Hedman, A.C.; Sayedyahossein, S.; Thapa, N.; Sacks, D.B.; Anderson, R.A. Agonist-stimulated phosphatidylinositol- 3,4,5-trisphosphate generation by scaffolded phosphoinositide kinases. Nat. Cell Biol. 2016, 18, 1324–1335. [Google Scholar] [CrossRef] [Green Version]
- Johnson, M.; Sharma, M.; Henderson, B.R. IQGAP1 regulation and roles in cancer. Cell. Signal. 2009, 21, 1471–1478. [Google Scholar] [CrossRef]
- White, C.D.; Brown, M.D.; Sacks, D.B. IQGAPs in cancer: A family of scaffold proteins underlying tumorigenesis. FEBS Lett. 2009, 583, 1817–1824. [Google Scholar] [CrossRef] [Green Version]
- Patel, V.; Hood, B.L.; Molinolo, A.A.; Lee, N.H.; Conrads, T.P.; Braisted, J.C.; Krizman, D.B.; Veenstra, T.D.; Gutkind, J.S. Proteomic analysis of laser-captured paraffin-embedded tissues: A molecular portrait of head and neck cancer progression. Clin. Cancer Res. 2008, 14, 1002–1014. [Google Scholar] [CrossRef] [Green Version]
- Wu, C.-C.; Li, H.; Xiao, Y.; Yang, L.-L.; Chen, L.; Deng, W.-W.; Wu, L.; Zhang, W.-F.; Sun, Z.-J. Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma. J. Mol. Histol. 2018, 49, 389–398. [Google Scholar] [CrossRef]
- Wei, T.; Choi, S.; Buehler, D.; Anderson, R.A.; Lambert, P.F. A PI3K/AKT scaffolding protein, IQ motif–containing GTPase associating protein 1 (IQGAP1), promotes head and neck carcinogenesis. Clin. Cancer Res. 2020, 26, 301–311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, M.; Choi, S.; Jung, O.; Wen, T.; Baum, C.; Thapa, N.; Lambert, P.F.; Rapraeger, A.C.; Anderson, R.A. The Specificity of EGF-Stimulated IQGAP1 Scaffold Towards the PI3K-Akt Pathway is Defined by the IQ3 motif. Sci. Rep. 2019, 9, 9126. [Google Scholar] [CrossRef] [PubMed]
- Wei, T.; Buehler, D.; Ward-Shaw, E.; Lambert, P.F. An infection-based murine model for papillomavirus-associated head and neck cancer. MBio 2020, 11. [Google Scholar] [CrossRef]
- Lambert, P.F. Transgenic Mouse Models of Tumor Virus Action. Annu. Rev. Virol. 2016, 3, 473–489. [Google Scholar] [CrossRef]
- Song, S.; Pitot, H.C.; Lambert, P.F. The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals. J. Virol. 1999, 73, 5887–5893. [Google Scholar] [CrossRef] [Green Version]
- Herber, R.; Liem, A.; Pitot, H.; Lambert, P.F. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 1996, 70, 1873–1881. [Google Scholar] [CrossRef] [Green Version]
- Tang, X.; Knudsen, B.; Bemis, D.; Tickoo, S.; Gudas, L.J. Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-treated Mice. Clin. Cancer Res. 2003, 10, 301–313. [Google Scholar] [CrossRef] [Green Version]
- Strati, K.; Pitot, H.C.; Lambert, P.F. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc. Natl. Acad. Sci. USA 2006, 103, 14152–14157. [Google Scholar] [CrossRef] [Green Version]
- Ingle, A.; Ghim, S.; Joh, J.; Chepkoech, I.; Jenson, A.B.; Sundberg, J.P. Novel Laboratory Mouse Papillomavirus (MusPV) Infection. Vet. Pathol. 2011, 48, 500–505. [Google Scholar] [CrossRef]
- Cladel, N.M.; Budgeon, L.R.; Balogh, K.K.; Cooper, T.K.; Hu, J.; Christensen, N.D. Mouse papillomavirus MmuPV1 infects oral mucosa and preferentially targets the base of the tongue. Virology 2016, 488, 73–80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Spurgeon, M.E.; Uberoi, A.; McGregor, S.M.; Wei, T.; Ward-Shaw, E.; Lambert, P.F. A Novel In Vivo Infection Model To Study Papillomavirus-Mediated Disease of the Female Reproductive Tract. MBio 2019, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Spurgeon, M.E.; Lambert, P.F. MmuPV1: A New Frontier in Animal Models of Papillomavirus Pathogenesis. J. Virol. 2020. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Uberoi, A.; Yoshida, S.; Frazer, I.H.; Pitot, H.C.; Lambert, P.F. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease. PLoS Pathog. 2016, 12, e1005664. [Google Scholar] [CrossRef]
- Piboonniyom, S.; Duensing, S.; Swilling, N.W.; Hasskarl, J.; Hinds, P.W.; Münger, K. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res. 2003, 63, 476–483. [Google Scholar]
- Li, S.; Wang, Q.; Chakladar, A.; Bronson, R.T.; Bernards, A. Gastric Hyperplasia in Mice Lacking the Putative Cdc42 Effector IQGAP1. Mol. Cell. Biol. 2000, 20, 697–701. [Google Scholar] [CrossRef] [Green Version]
- Panayiotou, T.; Michael, S.; Zaravinos, A.; Demirag, E.; Achilleos, C.; Strati, K. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers. PLoS Pathog. 2020, 16, e1008468. [Google Scholar] [CrossRef] [Green Version]
- Handisurya, A.; Day, P.M.; Thompson, C.D.; Buck, C.B.; Pang, Y.-Y.S.; Lowy, D.R.; Schiller, J.T. Characterization of Mus musculus Papillomavirus 1 Infection In Situ Reveals an Unusual Pattern of Late Gene Expression and Capsid Protein Localization. J. Virol. 2013, 87, 13214–13225. [Google Scholar] [CrossRef] [Green Version]
- Uberoi, A.; Yoshida, S.; Lambert, P.F. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). J. Virol. Methods 2018, 253, 11–17. [Google Scholar] [CrossRef]
- Hopman, A.H.N.; Ramaekers, F.C.S.; Speel, E.J.M. Rapid Synthesis of Biotin-, Digoxigenin-, Trinitrophenyl-, and Fluorochrome-labeled Tyramides and Their Application for In Situ Hybridization Using CARD Amplification. J. Histochem. Cytochem. 1998, 46, 771–777. [Google Scholar] [CrossRef] [Green Version]
- Xue, X.Y.; Majerciak, V.; Uberoi, A.; Kim, B.H.; Gotte, D.; Chen, X.; Cam, M.; Lambert, P.F.; Zheng, Z.M. The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues. PLoS Pathog. 2017, 13, e1006715. [Google Scholar] [CrossRef]
- Spangle, J.M.; Münger, K. The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis. J. Virol. 2010, 84, 9398–9407. [Google Scholar] [CrossRef] [Green Version]
- Strickland, S.W.; Vande Pol, S. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. J. Virol. 2016, 90, 5611–5621. [Google Scholar] [CrossRef] [Green Version]
- Pim, D.; Massimi, P.; Dilworth, S.M.; Banks, L. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 2005, 24, 7830–7838. [Google Scholar] [CrossRef] [Green Version]
- Egawa, N.; Shiraz, A.; Crawford, R.; Saunders-Wood, T.; Yarwood, J.; Rogers, M.; Sharma, A.; Eichenbaum, G.; Doorbar, J. Dynamics of papillomavirus in vivo disease formation & susceptibility to high-level disinfection—Implications for transmission in clinical settings. EBioMedicine 2021, 63. [Google Scholar] [CrossRef]
- Branca, M.; Ciotti, M.; Santini, D.; Di Bonito, L.; Benedetto, A.; Giorgi, C.; Paba, P.; Favalli, C.; Costa, S.; Agarossi, A.; et al. Activation of the ERK/MAP Kinase Pathway in Cervical Intraepithelial Neoplasia Is Related to Grade of the Lesion but Not to High-Risk Human Papillomavirus, Virus Clearance, or Prognosis in Cervical Cancer on behalf of the HPV-Pathogen ISS Study Group. Am. J. Clin. Pathol. 2004, 122, 902–911. [Google Scholar] [CrossRef]
- Rong, C.; Muller, M.; Flechtenmacher, C.; Holzinger, D.; Dyckhoff, G.; Bulut, O.C.; Horn, D.; Plinkert, P.; Hess, J.; Affolter, A. Differential activation of erk signaling in hpv-related oropharyngeal squamous cell carcinoma. Cancers 2019, 11, 584. [Google Scholar] [CrossRef] [Green Version]
- Smith, J.M.; Hedman, A.C.; Sacks, D.B. IQGAPs choreograph cellular signaling from the membrane to the nucleus. Trends Cell Biol. 2015, 25, 171–184. [Google Scholar] [CrossRef] [Green Version]
- Dongol, S.; Zhang, Q.; Qiu, C.; Sun, C.; Zhang, Z.; Wu, H.; Kong, B. IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer. Oncol. Lett. 2020, 20, 1179–1192. [Google Scholar] [CrossRef]
- Jinawath, N.; Shiao, M.S.; Chanpanitkitchote, P.; Svasti, J.; Furukawa, Y.; Nakamura, Y. Enhancement of migration and invasion of gastric cancer cells by iqgap3. Biomolecules 2020, 10, 1194. [Google Scholar] [CrossRef]
- Liu, Z.; Li, X.; Ma, J.; Li, D.; Ju, H.; Liu, Y.; Chen, Y.; He, X.; Zhu, Y. Integrative analysis of the iq motif-containing gtpase-activating protein family indicates that the iqgap3-pik3c2b axis promotes invasion in colon cancer. OncoTargets Ther. 2020, 13, 8299–8311. [Google Scholar] [CrossRef]
- Yang, Y.; Zhao, W.; Xu, Q.W.; Wang, X.S.; Zhang, Y.; Zhang, J. IQGAP3 promotes EGFR-ERK signaling and the growth and metastasis of lung cancer cells. PLoS ONE 2014, 9, e97578. [Google Scholar] [CrossRef] [Green Version]
- Nojima, H.; Adachi, M.; Matsui, T.; Okawa, K.; Tsukita, S.; Tsukita, S. IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nat. Cell Biol. 2008, 10, 971–978. [Google Scholar] [CrossRef]
- Xu, J.; Liu, H.; Yang, Y.; Wang, X.; Liu, P.; Li, Y.; Meyers, C.; Banerjee, N.S.; Wang, H.K.; Cam, M.; et al. Genome-wide profiling of cervical rna-binding proteins identifies human papillomavirus regulation of rnaseh2a expression by viral e7 and e2f1. MBio 2019, 10. [Google Scholar] [CrossRef] [Green Version]
- Doorbar, J.; Quint, W.; Banks, L.; Bravo, I.G.; Stoler, M.; Broker, T.R.; Stanley, M.A. The Biology and Life-Cycle of Human Papillomaviruses. Vaccine 2012, 30, F55–F70. [Google Scholar] [CrossRef]
- Meyers, J.M.; Uberoi, A.; Grace, M.; Lambert, P.F.; Munger, K. Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. PLoS Pathog. 2017, 13, e1006171. [Google Scholar] [CrossRef] [Green Version]
- Surviladze, Z.; Sterk, R.T.; DeHaro, S.A.; Ozbun, M.A. Cellular Entry of Human Papillomavirus Type 16 Involves Activation of the Phosphatidylinositol 3-Kinase/Akt/mTOR Pathway and Inhibition of Autophagy. J. Virol. 2013, 87, 2508–2517. [Google Scholar] [CrossRef] [Green Version]
- Bossler, F.; Kuhn, B.J.; Günther, T.; Kraemer, S.J.; Khalkar, P.; Adrian, S.; Lohrey, C.; Holzer, A.; Shimobayashi, M.; Dürst, M.; et al. Repression of human papillomavirus oncogene expression under hypoxia is mediated by PI3K/mTORC2/AKT signaling. MBio 2019, 10, 1–16. [Google Scholar] [CrossRef] [Green Version]
- Patel, V.; Rosenfeldt, H.M.; Lyons, R.; Servitja, J.M.; Bustelo, X.R.; Siroff, M.; Gutkind, J.S. Persistent activation of Rac1 in squamous carcinomas of the head and neck: Evidence for an EGFR/Vav2 signaling axis involved in cell invasion. Carcinogenesis 2007, 28, 1145–1152. [Google Scholar] [CrossRef] [Green Version]
- Deshmukh, J.; Pofahl, R.; Pfister, H.; Haase, I. Deletion of epidermal Rac1 inhibits HPV-8 induced skin papilloma formation and facilitates HPV-8- and UV-light induced skin carcinogenesis. Oncotarget 2016, 7, 57841–57850. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oliver, A.W.; He, X.; Borthwick, K.; Donne, A.J.; Hampson, L.; Hampson, I.N. The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br. J. Cancer 2011, 104, 324–331. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Morgan, E.L.; Macdonald, A. Autocrine STAT3 activation in hpv positive cervical cancer through a virus-driven Rac1— NFκB—IL-6 signalling axis. PLoS Pathog. 2019, 15, e1007835. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hart, M.J.; Callow, M.G.; Souza, B.; Polakis, P. IQGAP1, a calmodulin-binding protein with a rasGAP-related domain, is a potential effector for cdc42Hs. EMBO J. 1996, 15, 2997–3005. [Google Scholar] [CrossRef] [PubMed]
- Kuroda, S.; Fukata, M.; Kobayashi, K.; Nakafuku, M.; Nomura, N.; Iwamatsu, A.; Kaibuchi, K. Identification of IQGAP as a putative target for the small GTPases, Cdc42 and Rac1. J. Biol. Chem. 1996, 271, 23363–23367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mataraza, J.M.; Briggs, M.W.; Li, Z.; Entwistle, A.; Ridley, A.J.; Sacks, D.B. IQGAP1 Promotes Cell Motility and Invasion. J. Biol. Chem. 2003, 278, 41237–41245. [Google Scholar] [CrossRef] [Green Version]
- Brown, M.D.; Sacks, D.B. IQGAP1 in cellular signaling: Bridging the GAP. Trends Cell Biol. 2006, 16, 242–249. [Google Scholar] [CrossRef]
- Handisurya, A.; Day, P.M.; Thompson, C.D.; Bonelli, M.; Lowy, D.R.; Schiller, J.T. Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1. PLoS Pathog. 2014, 10, e1004314. [Google Scholar] [CrossRef] [Green Version]
- Wang, W.; Uberoi, A.; Spurgeon, M.; Gronski, E.; Majerciak, V.; Lobanov, A.; Hayes, M.; Loke, A.; Zheng, Z.M.; Lambert, P.F. Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment. PLoS Pathog. 2020, 16, e1008206. [Google Scholar] [CrossRef]
- Joh, J.; Chilton, P.M.; Wilcher, S.A.; Zahin, M.; Park, J.; Proctor, M.L.; Ghim, S.; Jenson, A.B. T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1. Exp. Mol. Pathol. 2017, 103, 181–190. [Google Scholar] [CrossRef]
- Gorman, J.A.; Babich, A.; Dick, C.J.; Schoon, R.A.; Koenig, A.; Gomez, T.S.; Burkhardt, J.K.; Billadeau, D.D. The Cytoskeletal Adaptor Protein IQGAP1 Regulates TCR-Mediated Signaling and Filamentous Actin Dynamics. J. Immunol. 2012, 188, 6135–6144. [Google Scholar] [CrossRef] [Green Version]
- Okuyama, Y.; Nagashima, H.; Ushio-Fukai, M.; Croft, M.; Ishii, N.; So, T. IQGAP1 restrains T-cell cosignaling mediated by OX40. FASEB J. 2020, 34, 540–554. [Google Scholar] [CrossRef] [Green Version]
Cohort | n | Normal | Dysplasia | Invasive Carcinoma | ||
---|---|---|---|---|---|---|
Mild | Moderate | Severe | ||||
Mock Iqgap1+/+ | 8 | 5 | 2 | 0 | 1 | 0 |
Mock Iqgap1−/− | 6 | 4 | 2 | 0 | 0 | 0 |
MmuPV1 Iqgap1+/+ | 10 | 2 | 3 | 2 | 1 | 2 |
MmuPV1 Iqgap1+/+ | 9 | 6 | 1 | 2 | 0 | 0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wei, T.; Choi, S.; Buehler, D.; Lee, D.; Ward-Shaw, E.; Anderson, R.A.; Lambert, P.F. Role of IQGAP1 in Papillomavirus-Associated Head and Neck Tumorigenesis. Cancers 2021, 13, 2276. https://doi.org/10.3390/cancers13092276
Wei T, Choi S, Buehler D, Lee D, Ward-Shaw E, Anderson RA, Lambert PF. Role of IQGAP1 in Papillomavirus-Associated Head and Neck Tumorigenesis. Cancers. 2021; 13(9):2276. https://doi.org/10.3390/cancers13092276
Chicago/Turabian StyleWei, Tao, Suyong Choi, Darya Buehler, Denis Lee, Ella Ward-Shaw, Richard A. Anderson, and Paul F. Lambert. 2021. "Role of IQGAP1 in Papillomavirus-Associated Head and Neck Tumorigenesis" Cancers 13, no. 9: 2276. https://doi.org/10.3390/cancers13092276